Foresee Pharmaceuticals Co., Ltd.

NT$71.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6576Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 0.55%
Div yield —
ROE 2.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.61
PE TTM 499.7
TSR TTM (8.52%)
Mkt cap NT$11.33B
ROIC (14.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$78
8.61%
(75.00%)
Hold 7|8|5|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.43
1.50
1.56
1.71
35.74%
27.55%
30.34%
29.03%
RevenueNT$M
839.4
837.3
825.5
822.4
6.71%
1.29%
0.79%
(4.73%)
Peers (US$342.1M)
Cap (US$)
PE
444.5M
17.80x
360.2M
10.47x
298.5M
10.62x
342.6M
—
Capital
TTM
5Y
10Y
Leveragex
1.079
(0.068)
(0.073)
EBIT/Intx
1.345
1.049
1.111
Own earn%
48.13
(12.29)
(29.00)
Sh yield%
40.86
43.74
40.89
Owners
Insiders/Inst%
5.61
64.22
Short interest%
1.90
SBC / revenue%
4.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
6–11
$1 testx
−0.1
Incr. ROIC%
19